CJC-1295 no DAC 10mg

"No DAC" indicates the absence of the drug affinity complex modification found in some CJC-1295 variants, resulting in a shorter research half-life and different research applications.

Broadly yes, with a caveat. Mod GRF 1-29 (modified GRF 1-29) is the same modified 29-amino-acid GHRH fragment sold as CJC-1295 No DAC. The name CJC-1295 on its own usually refers to the DAC-bound version, which is a different molecule with a much longer half-life — so "CJC-1295 No DAC" and "Mod GRF 1-29" describe this product, while "CJC-1295 with DAC" does not.

CJC 1295 peptide is the same compound as CJC-1295 — the hyphen is often dropped, and it also appears as CJC1295. It is a synthetic analogue of growth hormone-releasing hormone, supplied by PhaseOne in the No DAC form for laboratory research use only.

The DAC version carries a Drug Affinity Complex that binds albumin and extends its half-life to roughly a week; the No DAC form clears within hours. That difference changes how each is handled in study design. PhaseOne stocks the No DAC form only.

They act at different receptors. CJC-1295 No DAC is a GHRH analogue binding the GHRH receptor; Ipamorelin is a selective secretagogue acting at the ghrelin receptor. Because the mechanisms are complementary rather than overlapping, the two are commonly studied together. (!) View our Ipamorelin.

Both are GHRH-based. Sermorelin is the unmodified 29-amino-acid fragment, while Mod GRF 1-29 (CJC-1295 No DAC) carries four amino acid substitutions that resist enzymatic breakdown. PhaseOne stocks the modified form.

PhaseOne supplies both Australia-wide, separately or as a single blended vial. The two are studied together often enough that the blend saves reconstituting twice. (!) View our Ipamorelin or the CJC-1295 + Ipamorelin blend.

Yes — PhaseOne has CJC 1295 No DAC for sale online in 10mg vials, shipped Australia-wide. The thing worth checking on any listing is which form is being sold, since DAC and No DAC are different molecules and some listings use the name CJC-1295 without specifying. Every PhaseOne vial ships with a batch Certificate of Analysis.

PhaseOne prices CJC-1295 No DAC at A$69.99 for a 10mg vial, with the batch Certificate of Analysis included at no extra cost. Current pricing is shown on this page.

No. CJC-1295 is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it. It is supplied as a research compound through research suppliers instead.

Yes - the two are frequently studied together within Australian peptide research due to their complementary GHRH and secretagogue receptor mechanisms. View our Ipamorelin.

Both are GHRH analogues studied within Australian peptide research, but Tesamorelin is a longer, stabilised chain while CJC-1295 No DAC has a shorter research half-life. Compare with our Tesamorelin.

Unreconstituted CJC-1295 No DAC should be stored refrigerated and protected from light, and is commonly reconstituted using bacteriostatic water prior to research preparation. Read our reconstitution guide.

Every batch sold across Australia by PhaseOne is independently HPLC tested, with a Certificate of Analysis confirming identity and purity.

CJC-1295 No DAC is currently supplied in 10mg vials, shipped Australia-wide with full batch documentation.